What happened during the study?
The entire study took 3 years and 7 months to finish.
The study started in November 2016 and ended in June 2020.
The chart below shows what happened for Group 1 during the study.
Before the participants got study treatment
1 visit
The study doctors:
checked the health of the participants to took pictures of the participants’ tumors
make sure they could join the study using CT or MRI scans
did a physical exam and asked about the took blood and urine samples
participants’ medications and any medical
problems
if needed, used surgery to take a
sample of the tumor, also known
checked the participants’ heart health using
as a biopsy
an electrocardiogram, also called an ECG
4 weeks
During the first 16 weeks that the participants got study treatment
4 visits
The study doctors:
did a physical exam and asked about the took blood and urine samples
participants’ medications and any medical
problems
The participants:
if needed, checked the participants’ heart
health using an ECG got IV infusions of durvalumab with
tremelimumab once every 4 weeks
took pictures of the participants’ tumors
using CT or MRI scans at some visits
16 weeks
After the first 16 weeks that the participants got study treatment
1 visit per month
The study doctors:
did a physical exam and asked about the took blood and urine samples
participants’ medications and any medical
problems
The participants:
if needed, checked the participants’ heart got IV infusions of durvalumab
health using an ECG once every 4 weeks
took pictures of the participants’ tumors
using CT or MRI scans every 8 weeks
Until the participants left the study or the study doctors thought the
study treatments were no longer helping them
5 | Clinical Study Results